Global Vaccine Delivery Devices Market Size Study, By Devices (Syringes, Jet Injectors), By Route of Administration (Intradermal, Intramuscular, Subcutaneous), By End-User (Hospitals & Clinics, Home Care Settings, Ambulatory Surgery Centers), and Regional Forecasts 2022-2032
Global Vaccine Delivery Devices Market is estimated to grow significantly from USD 6.88 billion in 2023 to USD 13.30 billion by 2032, at a CAGR of 7.6% during the forecast period 2024-2032. The growing focus on efficient, precise, and safe immunization solutions drives the demand for advanced vaccine delivery devices. These devices, including syringes, jet injectors, and other innovative tools, have become integral to large-scale immunization programs and healthcare initiatives.
The market's expansion is underpinned by several factors, such as increasing investments in vaccine development, government-backed immunization programs, and a growing focus on pandemic preparedness. Additionally, the transition toward needle-free technologies addresses key safety concerns, including needlestick injuries and risks of contamination. Collaborations, like Pfizer and Acuitas Therapeutics' partnership for lipid nanoparticle delivery systems for mRNA vaccines, demonstrate the ongoing advancements in this field.
Globally, healthcare providers are increasingly leveraging vaccine delivery devices across diverse settings, including hospitals, clinics, home care environments, and ambulatory surgery centers. Each end-user segment plays a pivotal role in expanding immunization coverage and enhancing patient convenience.
Geographically, North America leads the market due to its advanced healthcare infrastructure, high awareness, and robust immunization programs. Europe closely follows, marked by strong public health initiatives and adoption of innovative technologies. Meanwhile, Asia Pacific exhibits rapid growth driven by population dynamics, increased healthcare spending, and expansive vaccination campaigns.
The industry's commitment to eco-friendly solutions and sustainable practices further aligns with global environmental goals, creating opportunities for manufacturers. Emerging markets are also poised to provide substantial growth prospects as they enhance healthcare access and infrastructure.
Major market players included in this report are:
By Devices:
North America
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
The market's expansion is underpinned by several factors, such as increasing investments in vaccine development, government-backed immunization programs, and a growing focus on pandemic preparedness. Additionally, the transition toward needle-free technologies addresses key safety concerns, including needlestick injuries and risks of contamination. Collaborations, like Pfizer and Acuitas Therapeutics' partnership for lipid nanoparticle delivery systems for mRNA vaccines, demonstrate the ongoing advancements in this field.
Globally, healthcare providers are increasingly leveraging vaccine delivery devices across diverse settings, including hospitals, clinics, home care environments, and ambulatory surgery centers. Each end-user segment plays a pivotal role in expanding immunization coverage and enhancing patient convenience.
Geographically, North America leads the market due to its advanced healthcare infrastructure, high awareness, and robust immunization programs. Europe closely follows, marked by strong public health initiatives and adoption of innovative technologies. Meanwhile, Asia Pacific exhibits rapid growth driven by population dynamics, increased healthcare spending, and expansive vaccination campaigns.
The industry's commitment to eco-friendly solutions and sustainable practices further aligns with global environmental goals, creating opportunities for manufacturers. Emerging markets are also poised to provide substantial growth prospects as they enhance healthcare access and infrastructure.
Major market players included in this report are:
- Becton Dickinson & Company
- Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)
- PharmaJet
- Vaxxas
- Gerresheimer AG
- SCHOTT AG
- Corium International, Inc.
- 3M
- Sinovac Biotech Ltd
- Pfizer Inc.
- Acuitas Therapeutics
- Kindeva Drug Delivery
- Summit Biosciences Inc.
- Bavarian Nordic
- Serum Institute of India
By Devices:
- Syringes
- Jet Injectors
- Intradermal Vaccination
- Intramuscular Vaccination
- Subcutaneous Vaccination
- Hospitals & Clinics
- Home Care Settings
- Ambulatory Surgery Centers
North America
- U.S.
- Canada
- Mexico
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Brazil
- Argentina
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
- Market Estimates & Forecast for 10 years from 2022 to 2032.
- Annualized revenues and regional level analysis for each market segment.
- Detailed analysis of geographical landscape with country-level analysis of major regions.
- Competitive landscape with information on major players in the market.
- Analysis of key business strategies and recommendations on future market approach.
- Analysis of competitive structure of the market.
- Demand-side and supply-side analysis of the market.
CHAPTER 1. GLOBAL VACCINE DELIVERY DEVICES MARKET EXECUTIVE SUMMARY
1.1. Global Vaccine Delivery Devices Market Size & Forecast (2022–2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Devices
1.3.2. By Route of Administration
1.3.3. By End-User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
CHAPTER 2. GLOBAL VACCINE DELIVERY DEVICES MARKET DEFINITION AND RESEARCH ASSUMPTIONS
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
CHAPTER 3. GLOBAL VACCINE DELIVERY DEVICES MARKET DYNAMICS
3.1. Market Drivers
3.1.1. Increasing Global Immunization Programs
3.1.2. Advancements in Needle-Free Vaccine Delivery Technologies
3.1.3. Growing Research and Development Investments
3.2. Market Challenges
3.2.1. High Costs Associated with Advanced Devices
3.2.2. Limited Cold Chain Infrastructure in Emerging Markets
3.3. Market Opportunities
3.3.1. Expansion in Emerging Economies
3.3.2. Focus on Eco-Friendly Delivery Systems
CHAPTER 4. GLOBAL VACCINE DELIVERY DEVICES MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE & FORECAST BY DEVICES 2022–2032
5.1. Segment Dashboard
5.2. Global Vaccine Delivery Devices Market: Devices Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.2.1. Syringes
5.2.2. Jet Injectors
CHAPTER 6. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE & FORECAST BY ROUTE OF ADMINISTRATION 2022–2032
6.1. Segment Dashboard
6.2. Global Vaccine Delivery Devices Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.2.1. Intradermal Vaccination
6.2.2. Intramuscular Vaccination
6.2.3. Subcutaneous Vaccination
CHAPTER 7. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE & FORECAST BY END-USER 2022–2032
7.1. Segment Dashboard
7.2. Global Vaccine Delivery Devices Market: End-User Revenue Trend Analysis, 2022 & 2032 (USD Million)
7.2.1. Hospitals & Clinics
7.2.2. Home Care Settings
7.2.3. Ambulatory Surgery Centers
CHAPTER 8. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE & FORECAST BY REGION 2022–2032
8.1. North America Vaccine Delivery Devices Market
8.1.1. U.S.
8.1.2. Canada
8.1.3. Mexico
8.2. Europe Vaccine Delivery Devices Market
8.2.1. UK
8.2.2. Germany
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Denmark
8.2.7. Sweden
8.2.8. Norway
8.3. Asia-Pacific Vaccine Delivery Devices Market
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. Australia
8.3.5. South Korea
8.3.6. Thailand
8.4. Latin America Vaccine Delivery Devices Market
8.4.1. Brazil
8.4.2. Argentina
8.4.3. Rest of Latin America
8.5. Middle East & Africa Vaccine Delivery Devices Market
8.5.1. Saudi Arabia
8.5.2. South Africa
8.5.3. UAE
8.5.4. Kuwait
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Becton Dickinson & Company
9.1.2. Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)
9.1.3. PharmaJet
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Becton Dickinson & Company
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)
9.3.3. PharmaJet
9.3.4. Vaxxas
9.3.5. Gerresheimer AG
9.3.6. SCHOTT AG
9.3.7. Corium International, Inc.
9.3.8. 3M
9.3.9. Sinovac Biotech Ltd
9.3.10. Pfizer Inc.
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process Overview
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
1.1. Global Vaccine Delivery Devices Market Size & Forecast (2022–2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Devices
1.3.2. By Route of Administration
1.3.3. By End-User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
CHAPTER 2. GLOBAL VACCINE DELIVERY DEVICES MARKET DEFINITION AND RESEARCH ASSUMPTIONS
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
CHAPTER 3. GLOBAL VACCINE DELIVERY DEVICES MARKET DYNAMICS
3.1. Market Drivers
3.1.1. Increasing Global Immunization Programs
3.1.2. Advancements in Needle-Free Vaccine Delivery Technologies
3.1.3. Growing Research and Development Investments
3.2. Market Challenges
3.2.1. High Costs Associated with Advanced Devices
3.2.2. Limited Cold Chain Infrastructure in Emerging Markets
3.3. Market Opportunities
3.3.1. Expansion in Emerging Economies
3.3.2. Focus on Eco-Friendly Delivery Systems
CHAPTER 4. GLOBAL VACCINE DELIVERY DEVICES MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE & FORECAST BY DEVICES 2022–2032
5.1. Segment Dashboard
5.2. Global Vaccine Delivery Devices Market: Devices Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.2.1. Syringes
5.2.2. Jet Injectors
CHAPTER 6. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE & FORECAST BY ROUTE OF ADMINISTRATION 2022–2032
6.1. Segment Dashboard
6.2. Global Vaccine Delivery Devices Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.2.1. Intradermal Vaccination
6.2.2. Intramuscular Vaccination
6.2.3. Subcutaneous Vaccination
CHAPTER 7. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE & FORECAST BY END-USER 2022–2032
7.1. Segment Dashboard
7.2. Global Vaccine Delivery Devices Market: End-User Revenue Trend Analysis, 2022 & 2032 (USD Million)
7.2.1. Hospitals & Clinics
7.2.2. Home Care Settings
7.2.3. Ambulatory Surgery Centers
CHAPTER 8. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE & FORECAST BY REGION 2022–2032
8.1. North America Vaccine Delivery Devices Market
8.1.1. U.S.
8.1.2. Canada
8.1.3. Mexico
8.2. Europe Vaccine Delivery Devices Market
8.2.1. UK
8.2.2. Germany
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Denmark
8.2.7. Sweden
8.2.8. Norway
8.3. Asia-Pacific Vaccine Delivery Devices Market
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. Australia
8.3.5. South Korea
8.3.6. Thailand
8.4. Latin America Vaccine Delivery Devices Market
8.4.1. Brazil
8.4.2. Argentina
8.4.3. Rest of Latin America
8.5. Middle East & Africa Vaccine Delivery Devices Market
8.5.1. Saudi Arabia
8.5.2. South Africa
8.5.3. UAE
8.5.4. Kuwait
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Becton Dickinson & Company
9.1.2. Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)
9.1.3. PharmaJet
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Becton Dickinson & Company
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)
9.3.3. PharmaJet
9.3.4. Vaxxas
9.3.5. Gerresheimer AG
9.3.6. SCHOTT AG
9.3.7. Corium International, Inc.
9.3.8. 3M
9.3.9. Sinovac Biotech Ltd
9.3.10. Pfizer Inc.
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process Overview
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
